Company intelligence / Profile preview

Beijing Bohui Innovation Biotechnology Group Co., Ltd.

Beijing, Beijing, China

Ownership: Private
Employees: ~2179
Development stage: Other

Overview

Beijing Bohui Innovation Biotechnology Group Co., Ltd. is a publicly traded biopharmaceutical company in China, specializing in blood products, vaccines, in vitro diagnostics, and instruments. Key activities include the development and manufacturing of fully automated nucleic acid detection kits. The company has expanded internationally through acquisitions, including US-based mass spectrometry company Advion Inc. and France-based chromatography provider Interchim group.

Industry: Biotech

Drug pipeline

1 asset

lyophilized human rabies vaccine

Beyond the preview

Go deeper on Beijing Bohui Innovation Biotechnology Group Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beijing Bohui Innovation Biotechnology Group Co., Ltd..

Explore the full profile